Israel Carsten W, Grönefeld Gerian, Ehrlich Joachim R, Li Yi-Gang, Hohnloser Stefan H
Department of Medicine, Division of Cardiology, J.W. Goethe-University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
J Cardiovasc Electrophysiol. 2003 Sep;14(9):954-9. doi: 10.1046/j.1540-8167.2003.03160.x.
Immediate reinitiation of atrial tachyarrhythmia (IRAT) is an important cause of failure to maintain sinus rhythm. IRAT prevention by overdrive pacing has not been evaluated in a prospective randomized trial.
Patients with a DDDRP pacemaker offering temporary atrial overdrive pacing after AT termination (Post Mode Switching Overdrive Pacing [PMOP]) were enrolled into the prospective PIRAT (Prevention of IRAT) trial if paroxysmal AT episodes occurred after implantation. PMOP was randomly activated (120 beats/min for 2 min) or inactive. After 3 months, device memory was interrogated, symptoms and quality of life assessed, and patients crossed over to the alternative treatment arm for another 3 months. Primary study endpoint was the number of AT episodes; secondary endpoints were the cumulative time in AT (AT burden), percentage of AT episodes with IRAT, symptoms, and quality of life with PMOP active versus inactive. In 37 patients (21 men; 69 +/- 9 years), there was no difference in the median number of AT episodes (0.37 vs 0.34 per day), AT burden (both 1%), percentage of episodes with IRAT (30%vs 28%), symptoms, and quality of life during PMOP off versus on. With PMOP active, 29% of 439 ATs restarted during and 18% before PMOP intervention. The PMOP-induced rate increase appeared to be associated with IRAT in 9% of AT episodes.
Automatic overdrive pacing after AT termination did not prevent IRAT, mainly due to insufficient overdrive suppression even at 120 beats/min and the delay between AT termination and PMOP intervention.
房性快速性心律失常的即刻复发(IRAT)是未能维持窦性心律的一个重要原因。通过超速起搏预防IRAT尚未在前瞻性随机试验中进行评估。
植入后发生阵发性房性心动过速(AT)发作的患者,若其DDDRP起搏器在AT终止后提供临时房性超速起搏(模式转换后超速起搏[PMOP]),则被纳入前瞻性PIRAT(预防IRAT)试验。PMOP被随机激活(120次/分钟,持续2分钟)或不激活。3个月后,询问设备内存,评估症状和生活质量,患者交叉至另一治疗组再进行3个月的治疗。主要研究终点是AT发作次数;次要终点是AT累计时间(AT负荷)、伴有IRAT的AT发作百分比、症状以及PMOP激活与未激活时的生活质量。在37例患者(21例男性;69±9岁)中,PMOP关闭与开启时,AT发作中位数(每天0.37次对0.34次)、AT负荷(均为1%)、伴有IRAT的发作百分比(30%对28%)、症状及生活质量均无差异。PMOP激活时,439次AT中有29%在PMOP干预期间复发,18%在PMOP干预前复发。PMOP引起的心率增加似乎与9%的AT发作中的IRAT有关。
AT终止后的自动超速起搏未能预防IRAT,主要原因是即使在120次/分钟时超速抑制也不足,以及AT终止与PMOP干预之间存在延迟。